Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases

Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of pat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lidiya V. Boldyreva, Maryana V. Morozova, Snezhanna S. Saydakova, Elena N. Kozhevnikova
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
IBD
Acceso en línea:https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb46
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ca7f68fc3d274d98b14d5ea15fe7cb46
record_format dspace
spelling oai:doaj.org-article:ca7f68fc3d274d98b14d5ea15fe7cb462021-11-11T17:08:42ZFat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases10.3390/ijms2221116821422-00671661-6596https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb462021-10-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11682https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of patients. Metabolic deregulation is indicative of IBD, including substantial shifts in lipid metabolism. Recent data showed that changes in some phospholipids are very common in IBD patients. For instance, phosphatidylcholine (PC)/phosphatidylethanolamine (PE) and lysophosphatidylcholine (LPC)/PC ratios are associated with the severity of the inflammatory process. Composition of phospholipids also changes upon IBD towards an increase in arachidonic acid and a decrease in linoleic and a-linolenic acid levels. Moreover, an increase in certain phospholipid metabolites, such as lysophosphatidylcholine, sphingosine-1-phosphate and ceramide, can result in enhanced intestinal inflammation, malignancy, apoptosis or necroptosis. Because some phospholipids are associated with pathogenesis of IBD, they may provide a basis for new strategies to treat IBD. Current attempts are aimed at controlling phospholipid and fatty acid levels through the diet or via pharmacological manipulation of lipid metabolism.Lidiya V. BoldyrevaMaryana V. MorozovaSnezhanna S. SaydakovaElena N. KozhevnikovaMDPI AGarticleIBDCrohn’s diseaseulcerative colitisphosphatidylcholinelysophosphatidylcholinephosphatidylethanolamineBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11682, p 11682 (2021)
institution DOAJ
collection DOAJ
language EN
topic IBD
Crohn’s disease
ulcerative colitis
phosphatidylcholine
lysophosphatidylcholine
phosphatidylethanolamine
Biology (General)
QH301-705.5
Chemistry
QD1-999
spellingShingle IBD
Crohn’s disease
ulcerative colitis
phosphatidylcholine
lysophosphatidylcholine
phosphatidylethanolamine
Biology (General)
QH301-705.5
Chemistry
QD1-999
Lidiya V. Boldyreva
Maryana V. Morozova
Snezhanna S. Saydakova
Elena N. Kozhevnikova
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
description Inflammatory bowel diseases (IBD) comprise a distinct set of clinical symptoms resulting from chronic inflammation within the gastrointestinal (GI) tract. Despite the significant progress in understanding the etiology and development of treatment strategies, IBD remain incurable for thousands of patients. Metabolic deregulation is indicative of IBD, including substantial shifts in lipid metabolism. Recent data showed that changes in some phospholipids are very common in IBD patients. For instance, phosphatidylcholine (PC)/phosphatidylethanolamine (PE) and lysophosphatidylcholine (LPC)/PC ratios are associated with the severity of the inflammatory process. Composition of phospholipids also changes upon IBD towards an increase in arachidonic acid and a decrease in linoleic and a-linolenic acid levels. Moreover, an increase in certain phospholipid metabolites, such as lysophosphatidylcholine, sphingosine-1-phosphate and ceramide, can result in enhanced intestinal inflammation, malignancy, apoptosis or necroptosis. Because some phospholipids are associated with pathogenesis of IBD, they may provide a basis for new strategies to treat IBD. Current attempts are aimed at controlling phospholipid and fatty acid levels through the diet or via pharmacological manipulation of lipid metabolism.
format article
author Lidiya V. Boldyreva
Maryana V. Morozova
Snezhanna S. Saydakova
Elena N. Kozhevnikova
author_facet Lidiya V. Boldyreva
Maryana V. Morozova
Snezhanna S. Saydakova
Elena N. Kozhevnikova
author_sort Lidiya V. Boldyreva
title Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
title_short Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
title_full Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
title_fullStr Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
title_full_unstemmed Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
title_sort fat of the gut: epithelial phospholipids in inflammatory bowel diseases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ca7f68fc3d274d98b14d5ea15fe7cb46
work_keys_str_mv AT lidiyavboldyreva fatofthegutepithelialphospholipidsininflammatoryboweldiseases
AT maryanavmorozova fatofthegutepithelialphospholipidsininflammatoryboweldiseases
AT snezhannassaydakova fatofthegutepithelialphospholipidsininflammatoryboweldiseases
AT elenankozhevnikova fatofthegutepithelialphospholipidsininflammatoryboweldiseases
_version_ 1718432203484954624